Industry Fears Report-Writing Burden From Supply Chain Risk Guidance US FDA Is Drafting
Executive Summary
As agency prepares guidance on CARES Act requirement for risk management plans to help prevent shortages of critical medicines, industry raised concerns that a broad interpretation of the “life-saving drugs” term used in the legislation could make compliance challenging.